{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T19:08:50Z","timestamp":1782328130414,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ijantimicag.2005.02.013","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T11:53:47Z","timestamp":1115812427000},"page":"523-529","source":"Crossref","is-referenced-by-count":147,"title":["Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecycline"],"prefix":"10.1016","volume":"25","author":[{"suffix":"Jr.","given":"John E.","family":"Conte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Golden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Grace","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Zurlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.02.013_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/AAC.47.2.533-540.2003","article-title":"Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia","volume":"47","author":"Edelstein","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2165\/00003495-200464010-00005","article-title":"The glycylcyclines: a comparative review with the tetracyclines","volume":"64","author":"Zhanel","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/AAC.44.4.1085-1088.2000","article-title":"Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci","volume":"44","author":"Hoellman","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0732-8893(99)00092-9","article-title":"Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1203 recent clinical bacterial isolates","volume":"36","author":"Gales","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0924-8579(00)00198-9","article-title":"In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis","volume":"16","author":"Roblin","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","article-title":"Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study 1997 to 2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/AAC.48.1.323-325.2004","article-title":"In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance","volume":"48","author":"Betriu","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1128\/AAC.46.3.892-895.2002","article-title":"In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain","volume":"46","author":"Betriu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib9","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/AAC.45.9.2604-2608.2001","article-title":"Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones","volume":"45","author":"Kenny","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib10","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","article-title":"Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria","volume":"46","author":"Wallace","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0149-2918(04)90070-7","article-title":"Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients","volume":"26","author":"Postier","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib12","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/AAC.46.8.2358-2364.2002","article-title":"Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","article-title":"Intrapulmonary pharmacokinetics of linezolid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib14","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/AAC.45.10.2891-2896.2001","article-title":"Effects of AIDS and gender on steady-state plasma and intrapulmonary ethambutol concentrations","volume":"45","author":"Conte","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1128\/AAC.44.4.985-990.2000","article-title":"Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects","volume":"44","author":"Conte","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib16","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.40.7.1617","article-title":"Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects","volume":"40","author":"Conte","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/AAC.39.2.334","article-title":"Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin","volume":"39","author":"Conte","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib18","series-title":"Dietary guidelines for Americans","author":"Anonymous","year":"2000"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib19","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1152\/jappl.1986.60.2.532","article-title":"Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution","volume":"60","author":"Rennard","year":"1986","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF01484513","article-title":"Enzymatische harnstoffbestimmung im Blut und Serum im optischem Test nach Warburg","volume":"43","author":"Talke","year":"1965","journal-title":"Klin Wochschr"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1164\/ajrccm\/138.1.74","article-title":"Quantification of cells recovered by bronchoalveolar lavage. Comparison of cytocentrifuge preparations with the filter method","volume":"138","author":"Willcox","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib22","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1183\/09031936.93.03080886","article-title":"Azithromycin concentrations at the sites of pulmonary infection","volume":"3","author":"Baldwin","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib23","series-title":"Biostatistical analysis","first-page":"162","article-title":"Multisample hypotheses: the analysis of variance. Multiple comparisons","author":"Zar","year":"1984"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0924-8579(02)00031-6","article-title":"Standardization of pharmacokinetic\/pharmacodynamic (PK\/PD) terminology for anti-infective drugs","volume":"19","author":"Mouton","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib25","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1128\/AAC.47.6.1875-1881.2003","article-title":"Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.03.002","article-title":"In vitro activity of tigecycline (GAR-936) tested against 11859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections","volume":"49","author":"Fritsche","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.02.013_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1128\/AAC.44.4.943-949.2000","article-title":"In vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) against various gram-positive and gram-negative bacteria","volume":"44","author":"van Ogtrop","year":"2000","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:14:07Z","timestamp":1683094447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0924857905000610"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.02.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}